Induction of proinflammatory cytokines in human lung epithelial cells during Chlamydia pneumoniae infection

Infection and Immunity

Volumn 71, Issue 2, 2003, Pages 614-620

  Yang, Jun ^a,b   Hooper, W Craig ^a   Phillips, Donald J ^a   Tondella, Maria L ^a   Talkington, Deborah F ^a  

^a NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^b ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; DNA; GAMMA INTERFERON; HEPARIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CARCINOMA CELL; CELL LINE; CENTRIFUGATION; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DNA SYNTHESIS INHIBITION; GENE EXPRESSION; HUMAN; HUMAN CELL; LUNG ALVEOLUS EPITHELIUM; LUNG CARCINOMA; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION;

BACTERIAL ADHESION; CHLAMYDOPHILA PNEUMONIAE; CYTOKINES; EPITHELIAL CELLS; HEAT; HUMANS; INFLAMMATION; INTERLEUKIN-8; LUNG; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 0037307111     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.71.2.614-620.2003     Document Type: Article

References (52)

1. Airenne, S., H. M. Surcel, A. Bloigu, K. Laitinen, P. Saikku, and A. Laurila. 2000. The resistance of human monocyte-derived macrophages to Chlamydia pneumoniae infection is enhanced by interferon-gamma. APMIS 108:139-144.
2. Black, R. A., S. R. Kronhcim, M. Cantrell, M. C. Deeley, D. J. March, K. S. Prickett, J. Wignall, P. J. Conlon, D. Cosman, T. P. Hopp, and D. Y. Mochizuki. 1988. Generation of biologically active interleukin-1β by proteolytic cleavage of the inactive precursor. J. Biol. Chem. 263:9437-9442.
3. Campell, L. A., E. R. O'Brien, A. L. Cappuccio, C. C. Kuo, S. P. Wang, D. Stewart, D. L. Patton, P. K. Cummings, and J. T. Grayston. 1995. Detection of Chlamydia pneumoniae TWAR in human coronary atherectomy tissues. J. Infect. Dis. 172:585-588.
4. Carlin, J. M., and J. B. Weller. 1995. Potentiation of interferon-mediated inhibition of Chlamydia infection by interleukin-1 in human macrophage cultures. Infect. Immun. 63:1870-1875.
5. Caspar-Bauguil, S., B. Puissant, D. Nazzal, J.-C. Lefevre, M. Thomsen, R. Salvayre, and H. Benoist. 2000. Chlamydia pneumoniae induces interleukin-10 production that down-regulates major histocompatibility complex class I expression. J. Infect. Dis. 182:1394-1401.
6. Dechend, R., M. Maass, J. Gieffers, R. Dietz, C. Scheidereit, A. Leutz, and D. C. Gulba. 1999. Chlamydia pneumoniae infection of vascular smooth muscle and endothelial cells activates NF-KB and induces tissue factor and PAI-1 expression. Circulation 100:1369-1373.
7. Donath, B., C. Fischer, S. Page, S. Prebeck, N. Jilg, M. Weber, C. da Costa, D. Neumeier, T. Miethke, and K. Brand. 2002. Chlamydia pneumoniae activates IKK/IkappaB-mediated signaling, which is inhibited by 4-HNE following primary exposure. Atherosclerosis 165:79-88.
8. Eckmann, L., M. F. Lagnoff, and J. Fierer. 1995. Intestinal epithelial cells as watchdogs for the natural immune system. Trends Microbiol. 3:118-120.
9. Fenton, M. J., M. W. Vermeulen, S. Kim, M. Burdick, R. M. Strieter, and H. Kornfeld. 1997. Induction of gamma interferon production in human alveolar macrophages by Mycobacterium tuberculosis. Infect. Immun. 65:5149-5156.
10. Gan, X., and B. Bonavida. 1999. Preferential induction of TNF-α and IL-β and inhibition of IL-10 secretion by human peripheral blood monocytes by synthetic Aza-alkyl lysophopholipids. Cell. Immunol. 193:125-133.
11. Geng, Y., K. Berencsi, Z. Gyulai, T. Valyi-Nagy, E. Gonezol, and G. Trinchieri. 2000. Roles of interleukin-12 and gamma interferon in murine Chlamydia pneumoniae infection. Infect. Immun. 68:2245-2253.
12. Geng, Y., R. B. Shane, K. Berencsi, E. Gonezol, M. H. Zaki, D. J. Margolis, G. Trinchieri, and A. H. Rook. 2000. Chlamydia pneumoniae inhibits apoptosis in human peripheral blood mononuclear cells through induction of IL-10. J. Immunol. 164:5522-5529.
13. Gerard, H. C., Z. Wang, J. A. Whittum-Hudson, H. El-Gabalawy, R. Goldbach-Mansky, T. Bardin, H. R. Schumacher, and A. P. Hudson. 2002. Cytokine and chemokine mRNA produced in synovial tissue chronically infected with Chlamydia trachomatis and C pneumoniae. J. Rheumatol. 29:1827-1835.
14. Gibbs, R. G., N. Carey, and A. H. Davies. 1998. Chlamydia pneumoniae and vascular disease. Br. J. Surg. 85:1191-1197.
15. Hahn, D. L., and R. McDonald. 1998. Can acute Chlamydia pneumoniae respiratory infection initiate chronic asthma? Ann. Allergy Asthma Immunol. 81:339-344.
16. Halme, S., J. Latvala, R. Karttunen, I. Palatsi, P. Saikku, and H.-M. Surcel. 2000. Cell-mediated innune response during primary Chlamydia pneumoniae infection. Infect. Immun. 68:7156-7158.
17. Hannu, T., M. Puolakkainen, and M. Leirisalo-Repo. 1999. Chlamydia pneumoniae as a triggering infection in reactive arthritis. Rheumatology 38:411-444.
18. Hazuda, D. J., J. Strickler, P. Simon, and P. R. Young. 1991. Structure-function mapping of interleukin 1 precursors. Cleavage leads to a conformational change in the mature protein. J. Biol. Chem. 266:7081-7086.
19. Heinemann, M., M. Susa, U. Simnacher, R. Marre, and A. Essig. 1995. Growth of Chlamydia pneumoniae induces cytokine production and expression of CD14 in a human monocytic cell line. Infect. Immun. 64:4872-4875.
20. Igietseme, J. U., I. M. Uriri, M. Chow, E. Abe, and R. G. Rank. 1997. Inhibition of intracellular multiplication of human strains of Chlamydia trachomatis by nitric oxide. Biochem. Biophys. Res. Commun. 232:595-601.
21. Jahn, H.-U., M. Krull, F. N. Wuppermann, A. C. Klucken, S. Rosseau, J. Seybold, J. H. Hegemann, C. A. Jantos, and N. Suttorp. 2000. Infection and activation of airway epithelial cells by Chlamydia pneumoniae. J. Infect. Dis. 182:1678-1687.
22. Kaukoranta-Tolvanen, S.-S. E., A.-M. Teppo, K. Laitinen, P. Saikku, K. Linnavuori, and M. Leinonen. 1996. Growth of Chlamydia pneumoniae in cultured human peripheral blood mononuclear cells and induction of a cytokine response. Microb. Pathog. 21:215-221.
23. Kol, A., G. K. Sokova, A. H. Lichtman, P. Libby. 1998. Chlamydial heat shock protein 60 localizes in human atheroma and regulates macrophage tumor necrosis factor-alpha and matrix metalloproteinase expression. Circulation 98:300-307.
24. Kunkel, S. L., T. J. Standiford, K. Kasahara, and R. M. Strieter. 1991. Interleukin-8 (IL-8): the major neutrophil chemotactic factor in the lung. Exp. Lung. Res. 17:17-23.
25. Kuo, C. C., L. A. Jackson, L. A. Campbell, and J. T. Grayston. 1995. Chlamydia pneumoniae (TWAR). Clin. Microbiol. Rev. 8:451-461.
26. Lee, D. H., J. C. Park, and H. Suh. 2001. Effect of centrifugal force on cellular activity of osteoblastic MC3T3-E1 cells in vitro. Yonsei Med. J. 42:405-410.
27. Levine, S. J. 1995. Bronchial epithelial cell-cytokine interactions in airway inflammation. J. Investig. Med. 43:241-249.
28. Liechty, K. W., T. M. Crombleholme, D. L. Cass, B. Martin, and N. S. Adzick. 1998. Diminished interleukin-8 (IL-8) production in the fetal wound healing response. J. Surg. Res. 77:80-84.
29. Maccarrone, M., M. Bari, and A. Finazzi Agro. 1999. Lipid peroxidation and polyamine metabolism in K562 cells subjected to altered gravity. J. Gravit. Physiol. 6:25-26.
30. Matsushima, H., M. Shirai, K. Ouchi, K. Yamashita, T. Kakutani, S. Furukawa, and T. Nakazawa. 1999. Lymphotoxin inhibits Chlamydia pneumoniae growth in HEp-2 cells. Infect. Immun. 67:3175-3179.
31. Meylby, K. K., T. K. Kvien, A. Glennas, and G. Anestad. 1999. Chlamydia pneumoniae as a trigger of reactive arthritis. Scand. J. Infect. Dis. 31:327-328.
32. Molestina, R. E., R. D. Miller, A. B. Lentsch, J. A. Ramirez, and J. T. Summersgill. 2000. Requirement for NF-KB in transcriptional activation of monocyte chemotactic protein 1 by Chlamydia pneumoniae in human endothelial cells. Infect. Immun. 68:4282-4288.
33. Molestina, R. E., R. D. Miller, J. A. Ramirez, and J. T. Summersgill. 1999. Infection of human endothelial cells with Chlamydia pneumoniae stimulates transendothelial migration of neutrophils and monocytes. Infect. Immun. 67:1323-1330.
34. Mukaida, N., A. Harada, and K. Matsushima. 1998. Interleukin-8 (IL-8) and monocyte chemotactic and activating factor (MCAF/MCP-1), chemokines essentially involved in inflammatory and immune reactions. Cytokine Growth Factor Rev. 9:9-23.
35. Netea, M. G., C. H. Selzman, B. J. Kullberg, J. M. D. Galama, A. Weinberg, A. F. H. Stalenhoef, J. W. M. Van der Meer, and C. A. Dinarello. 2000. Acellular components of Chlamydia pneumoniae stimulate cytokine production in human blood mononuclear cells. Eur. J. Immunol. 30:541-549.
36. Pruckler, J. M., N. Masse, V. A. Stevens, L. Gang, Y. Yang, E. R. Zell, S. F. Dowell, and B. S. Fields. 1999. Optimizing culture of Chlamydia pneumoniae by using multiple centrifugations. J. Clin. Microbiol. 37:3399-3401.
37. Quinn, T. C., and C. A. Gaydos. 1999. In vitro infection and pathogenesis of Chlamydia pneumoniae in endovascular cells. Am. Heart J. 138:S507-S511.
38. Rajalingam, K., H. Al-Younes, A. Muller, T. F. Meyer, A. J. Szczepek, and T. Rudel. 2001. Epithelial cells infected with Chlamydophila pneumoniae (Chlamydia pneumoniae) are resistant to apoptosis. Infect. Immun. 69:7880-7888.
39. Redecke, V., K. Dalhoff, S. Bohnet, J. Braun, and M. Maass. 1998, Interaction of Chlamydia pneumoniae and human alveolar macrophages: infection and inflammatory response. Am. J. Respir. Cell Mol. Biol. 19:721-727.
40. Rodel, J., M. Woytas, A. Groh, K.-H. Schmidt, M. Hartmann, M. Lehmann, and E. Straube. 2000. Production of basic fibroblast growth factor and interleukin-6 by human smooth muscle cells following infection with Chlamydia pneumoniae. Infect. Immun. 68:3635-3641.
41. Rottenberg, M. E., A. Gigliotti Rothfuchs, D. Gigliotti, M. Ceausu, C. Une, V. Levitsky, and H. Wigzell. 2000. Regulation and role of IFN-gamma in the innate resistance to infection with Chlamydia pneumoniae. J. Immunol. 164:4812-4818.
42. Rottenberg, M. E., A. Gigliotti-Rothfuchs, and H. Wigzell. 2002. The role of IFN-gamma in the outcome of chlamydial infection. Curt. Opin. Immunol. 14:444-451.
43. Summersgill, J. T., N. N. Sahney, C. A. Gaydos, T. S. Quinn, and J. A. Ramirez. 1995. Inhibition of Chlamydia pneumoniae growth in HEp-2 cells pretreated with gamma interferon and tumor necrosis factor alpha. Infect. Immun. 63:2801-2803.
44. Theilig, C., A. Bernd, G. Leyhausen, R. Kaufmann, and W. Geurtsen. 2001. Effects of mechanical force on primary human fibroblasts derived from the gingiva and the periodontal ligament. J. Dent. Res. 80:1777-1800.
45. Thom, D. H., S. P. Wang, J. T. Grayston, D. S. Siscovick, D. K. Stewart, R. A. Kronmal, and N. S. Weiss. 1991. Chlamydia pneumoniae strain TWAR antibody and angiographically demonstrated coronary artery disease. Arterioscler. Thromb. 11:547-551.
46. Tjhie, J. H. T., R. Roosendaal, D. M. MacLaren, and C. M. Yandenbroucke-Grauls. 1997. Improvement of growth of Chlamydia pneumoniae on HEp-2 cells by pretreatment with polyethylene glycol in combination with additional centrifugation and extension of culture time. J. Clin. Microbiol. 35:1883-1884.
47. von Hertzen, L. C. 1998. Chlamydia pneumoniae and its role in chronic obstructive pulmonary diseases. Ann. Med. 30:27-37.
48. Wang, Y., and S. W. Walsh. 1996. TNF alpha concentrations and mRNA expression are increased in preeclampitc placentas. J. Reprod. Immunol. 32:157-169.
49. Ward, M. E. 1995. The immunobiology and immunopathology of chlamydial infections. APMIS 103:769-796.
50. Wong, K. H., S. K. Skelton, and Y. K. Chan. 1992. Efficient culture of Chlamydia pneumoniae with cell lines derived from the human respiratory tract. J. Clin. Microbiol. 30:1625-1630.
51. Wuppermann, F. N., J. H. Hegemann, and C. A. Jantos. 2001. Heparan sulfate-like glycosaminoglycan is a cellular receptor for Chlamydia pneumoniae. J. Infect. Dis. 184:181-187.
52. Yoshida, Y., M. Maruyama, T. Fujita, N. Arai, R. Hayashi, J. Araya, S. Matsui, N. Yamashita, E. Sugiyama, and M. Kobayashi. 1999. Reactive oxygen intermediates stimulate interleukin-6 production in human bronchial epithelial cells. Am. J. Physiol. 276:L900-L908.